Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioCorRx (BICX) Times Interest Earned (2016 - 2025)

BioCorRx's Times Interest Earned history spans 15 years, with the latest figure at -$10.06 for Q3 2025.

  • For Q3 2025, Times Interest Earned rose 9.7% year-over-year to -$10.06; the TTM value through Sep 2025 reached -$12.17, down 72.52%, while the annual FY2024 figure was -$6.59, 78.24% up from the prior year.
  • Times Interest Earned for Q3 2025 was -$10.06 at BioCorRx, up from -$38.67 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $6.73 in Q3 2021 and bottomed at -$98.01 in Q4 2021.
  • The 5-year median for Times Interest Earned is -$13.54 (2022), against an average of -$29.24.
  • The largest YoY upside for Times Interest Earned was 141.12% in 2021 against a maximum downside of 2733.75% in 2021.
  • A 5-year view of Times Interest Earned shows it stood at -$98.01 in 2021, then soared by 49.04% to -$49.94 in 2022, then surged by 52.38% to -$23.79 in 2023, then skyrocketed by 63.07% to -$8.78 in 2024, then dropped by 14.52% to -$10.06 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Times Interest Earned are -$10.06 (Q3 2025), -$38.67 (Q2 2025), and -$10.72 (Q1 2025).